BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 15382220)

  • 1. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
    Mandell MS
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
    Krowka MJ; Mandell MS; Ramsay MA; Kawut SM; Fallon MB; Manzarbeitia C; Pardo M; Marotta P; Uemoto S; Stoffel MP; Benson JT
    Liver Transpl; 2004 Feb; 10(2):174-82. PubMed ID: 14762853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portopulmonary hypertension and hepatopulmonary syndrome, and liver transplantation.
    Ramsay MA
    Int Anesthesiol Clin; 2006; 44(3):69-82. PubMed ID: 16832207
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
    Martínez-Palli G; Taurà P; Balust J; Beltrán J; Zavala E; Garcia-Valdecasas JC
    Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.
    Aucejo F; Miller C; Vogt D; Eghtesad B; Nakagawa S; Stoller JK
    Liver Transpl; 2006 Aug; 12(8):1278-82. PubMed ID: 16937330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Pham DM; Subramanian R; Parekh S
    J Clin Gastroenterol; 2010 Aug; 44(7):e136-40. PubMed ID: 20463591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary complications of cirrhosis.
    Singh C; Sager JS
    Med Clin North Am; 2009 Jul; 93(4):871-83, viii. PubMed ID: 19577119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
    Krowka MJ; Fallon MB; Mulligan DC; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatopulmonary syndrome and portopulmonary hypertension.
    Restrepo R; Singer EF; Baram M; Restrepo R; Singer EF; Baram M
    Hosp Pract (1995); 2013 Apr; 41(2):62-71. PubMed ID: 23680738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vascular abnormalities in cirrhosis.
    Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
    Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
    Krowka MJ; Wiesner RH; Heimbach JK
    J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation.
    Iqbal S; Smith KA; Khungar V
    Clin Chest Med; 2017 Dec; 38(4):785-795. PubMed ID: 29128026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease.
    Iqbal CW; Krowka MJ; Pham TH; Freese DK; El Youssef M; Ishitani MB
    J Pediatr Surg; 2008 Oct; 43(10):1813-20. PubMed ID: 18926213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders.
    Huffmyer JL; Nemergut EC
    Respir Care; 2007 Aug; 52(8):1030-6. PubMed ID: 17650360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: liver transplantation for the pulmonary disorders of portal hypertension.
    Houlihan DD; Holt A; Elliot C; Ferguson JW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):183-94. PubMed ID: 23146100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver in cardiopulmonary disease.
    Polavarapu N; Tripathi D
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):497-512. PubMed ID: 24090938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.